Literature DB >> 23757162

Palliative care consultation trajectories.

Elissa Kozlov1, Brian D Carpenter, Michael Thorsten, Mark Heiland, Anupam Agarwal.   

Abstract

BACKGROUND: Palliative care consultations teams (PCCTs) promote comprehensive health but only if the PCCT can influence actual care. The purpose of this study is to document the types of recommendations made by a PCCT, determine the rates at which recommendations are implemented, and identify the factors related to implementation.
RESULTS: The mean number of recommendations per patient was 1.44 (standard deviation = 1.81), and 57% of the recommendations were implemented. Discharge and goals of care recommendations were significantly more likely to be implemented than recommendations for pain, symptom management, and consultation of other services.
CONCLUSIONS: Although PCCTs may have suggestions about how to guide care, many of those recommendations are not implemented. Future research is needed to understand how to maximize the impact of PCCTs.

Entities:  

Keywords:  consultation; health services; interdisciplinary communication; interdisciplinary teams; palliative care; service utilization

Mesh:

Year:  2013        PMID: 23757162     DOI: 10.1177/1049909113491455

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  2 in total

1.  Case management in primary palliative care is associated more strongly with organisational than with patient characteristics: results from a cross-sectional prospective study.

Authors:  Annicka Gm van der Plas; Anneke L Francke; Kris C Vissers; Wim Jj Jansen; Luc Deliens; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2015-07-02       Impact factor: 3.234

2.  Barriers and Facilitators to Effective Inpatient Palliative Care Consultations: A Qualitative Analysis of Interviews With Palliative Care and Nonpalliative Care Providers.

Authors:  Meghan McDarby; Brian D Carpenter
Journal:  Am J Hosp Palliat Care       Date:  2018-08-14       Impact factor: 2.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.